BECN1 and uterine corpus leiomyoma: In conclusion, the key findings of the current study highlight the therapeutic value of MIF in the treatment of PR-M-positive uterine leiomyoma, which results in the autophagy and apoptosis of cancer cells by regulating Bcl-2/Beclin1 axis (Figure 7).